Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessGoldman Sachs Initiates Neutral Coverage on Doximity, Highlights Balanced Growth Potential

Goldman Sachs Initiates Neutral Coverage on Doximity, Highlights Balanced Growth Potential

Add to Favorite
Added to Favorite


Goldman Sachs analysts initiated coverage on Doximity (NYSE:DOCS) with a Neutral rating and a price target on the stock of $58. The evaluation reflects a balanced outlook, acknowledging the company’s strong market position and growth potential while noting limited upside at current valuation levels.
Doximity operates in an attractive end-market, holding a leadership position that supports its long-term growth prospects. Goldman Sachs projected sustained industry performance of 6-7% annually, with Doximity expected to outpace the market, driving a 9-10% compound annual revenue growth rate (CAGR) from fiscal 2025 through fiscal 2028. The company’s ability to expand its core customer base and achieve its fiscal 2025 guidance, as well as outer-year revenue forecasts, was further reinforced by its strong performance in the second quarter of fiscal 2025.
In addition to revenue growth, Goldman Sachs highlighted a clear trajectory for EBITDA margin expansion. The analysts forecasted an increase of 180 basis points in margins from fiscal 2025 to fiscal 2028, reflecting operational efficiencies and strong execution. While Doximity’s fundamentals remain robust, the Neutral rating suggests that current valuation levels already account for much of its growth potential, leaving limited room for near-term upside.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Advance Auto Parts Downgraded to Sell Amid Earnings Miss and Weak Outlook

CFRA analysts downgraded Advance Auto Parts (NYSE:AAP) from Hold...

Guggenheim Reiterates Buy Rating on Cabaletta Bio Amid Promising Data

Guggenheim analysts reaffirmed a Buy rating and a $23...

JPMorgan Downgrades bluebird bio to Underweight Following Q3 Results

JPMorgan analysts downgraded bluebird bio (NASDAQ:BLUE) from Neutral to...

Globant Shares Fall 3 percent Despite Solid Q3 Performance and Optimistic Guidance

Globant S.A. (NYSE:GLOB) saw its shares drop more than...